Result for tag: "biologics"
Phase I – III
TFS offers a full suite of clinical services and functional solutions on a global, regional, and local basis. Our global reach, focused therapeutic experience, client-centric approach, and robust tech...
Emerging Therapies for Atopic Dermatitis
Atopic dermatitis is a chronic, pruritic, inflammatory skin disease that occurs most frequently in children, but also a great number of adults. Clinical features of atopic dermatitis include skin dryn...
Key Challenges and Applied Approaches in Immuno-Oncology Trials
Immuno-oncology (I-0) has emerged as a promising area of research in oncology. The diverse investigational products that are currently under development in both the United States and the European Unio...
Phase IIIb Trial in Adolescent Patients with Plaque Psoriasis
As part of our experience in this indication, TFS is proud to present a case study of a Phase IIIb trial we conducted in adolescent patients with plaque psoriasis. This case study demonstrates our kno...
Dry Eye Disease Case Study
A rapidly growing, biopharmaceutical company, dedicated to developing innovative therapies and novel biologics for rare and underserved ocular disorders, aggressively pursues new treatments for ocular...